UniProt ID | TKT_HUMAN | |
---|---|---|
UniProt AC | P29401 | |
Protein Name | Transketolase | |
Gene Name | TKT | |
Organism | Homo sapiens (Human). | |
Sequence Length | 623 | |
Subcellular Localization | ||
Protein Description | Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate.. | |
Protein Sequence | MESYHKPDQQKLQALKDTANRLRISSIQATTAAGSGHPTSCCSAAEIMAVLFFHTMRYKSQDPRNPHNDRFVLSKGHAAPILYAVWAEAGFLAEAELLNLRKISSDLDGHPVPKQAFTDVATGSLGQGLGAACGMAYTGKYFDKASYRVYCLLGDGELSEGSVWEAMAFASIYKLDNLVAILDINRLGQSDPAPLQHQMDIYQKRCEAFGWHAIIVDGHSVEELCKAFGQAKHQPTAIIAKTFKGRGITGVEDKESWHGKPLPKNMAEQIIQEIYSQIQSKKKILATPPQEDAPSVDIANIRMPSLPSYKVGDKIATRKAYGQALAKLGHASDRIIALDGDTKNSTFSEIFKKEHPDRFIECYIAEQNMVSIAVGCATRNRTVPFCSTFAAFFTRAFDQIRMAAISESNINLCGSHCGVSIGEDGPSQMALEDLAMFRSVPTSTVFYPSDGVATEKAVELAANTKGICFIRTSRPENAIIYNNNEDFQVGQAKVVLKSKDDQVTVIGAGVTLHEALAAAELLKKEKINIRVLDPFTIKPLDRKLILDSARATKGRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPRSGKPAELLKMFGIDRDAIAQAVRGLITKA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MESYHKPD -------CCCCCCCC | 7.52 | 22814378 | |
1 | Sulfoxidation | -------MESYHKPD -------CCCCCCCC | 7.52 | 28183972 | |
3 | Phosphorylation | -----MESYHKPDQQ -----CCCCCCCCHH | 31.10 | 23401153 | |
3 (in isoform 2) | Phosphorylation | - | 31.10 | 27251275 | |
4 | Phosphorylation | ----MESYHKPDQQK ----CCCCCCCCHHH | 10.68 | 23186163 | |
4 (in isoform 2) | Phosphorylation | - | 10.68 | 27642862 | |
6 | 2-Hydroxyisobutyrylation | --MESYHKPDQQKLQ --CCCCCCCCHHHHH | 41.90 | - | |
6 | Acetylation | --MESYHKPDQQKLQ --CCCCCCCCHHHHH | 41.90 | 19608861 | |
6 | Malonylation | --MESYHKPDQQKLQ --CCCCCCCCHHHHH | 41.90 | 26320211 | |
6 | Ubiquitination | --MESYHKPDQQKLQ --CCCCCCCCHHHHH | 41.90 | 19608861 | |
11 | Ubiquitination | YHKPDQQKLQALKDT CCCCCHHHHHHHHHH | 36.61 | 21890473 | |
11 | Ubiquitination | YHKPDQQKLQALKDT CCCCCHHHHHHHHHH | 36.61 | 21890473 | |
11 | 2-Hydroxyisobutyrylation | YHKPDQQKLQALKDT CCCCCHHHHHHHHHH | 36.61 | - | |
11 | Acetylation | YHKPDQQKLQALKDT CCCCCHHHHHHHHHH | 36.61 | 19608861 | |
11 | Malonylation | YHKPDQQKLQALKDT CCCCCHHHHHHHHHH | 36.61 | 26320211 | |
11 | Ubiquitination | YHKPDQQKLQALKDT CCCCCHHHHHHHHHH | 36.61 | 19608861 | |
16 | Ubiquitination | QQKLQALKDTANRLR HHHHHHHHHHHHHHH | 56.92 | 21890473 | |
16 | Ubiquitination | QQKLQALKDTANRLR HHHHHHHHHHHHHHH | 56.92 | 21890473 | |
16 | 2-Hydroxyisobutyrylation | QQKLQALKDTANRLR HHHHHHHHHHHHHHH | 56.92 | - | |
16 | Acetylation | QQKLQALKDTANRLR HHHHHHHHHHHHHHH | 56.92 | 25953088 | |
16 | Malonylation | QQKLQALKDTANRLR HHHHHHHHHHHHHHH | 56.92 | 26320211 | |
16 | Ubiquitination | QQKLQALKDTANRLR HHHHHHHHHHHHHHH | 56.92 | - | |
39 | Phosphorylation | AAGSGHPTSCCSAAE CCCCCCCCCCCCHHH | 28.81 | 21082442 | |
40 | Phosphorylation | AGSGHPTSCCSAAEI CCCCCCCCCCCHHHH | 19.99 | 21082442 | |
55 | Phosphorylation | MAVLFFHTMRYKSQD HHHHHHHHCCCCCCC | 9.74 | 22210691 | |
59 | 2-Hydroxyisobutyrylation | FFHTMRYKSQDPRNP HHHHCCCCCCCCCCC | 31.13 | - | |
59 | Acetylation | FFHTMRYKSQDPRNP HHHHCCCCCCCCCCC | 31.13 | 26210075 | |
70 | Methylation | PRNPHNDRFVLSKGH CCCCCCCCEEEECCC | 28.96 | 115918541 | |
102 | 2-Hydroxyisobutyrylation | AELLNLRKISSDLDG HHHHCHHHCCCCCCC | 50.54 | - | |
102 | Ubiquitination | AELLNLRKISSDLDG HHHHCHHHCCCCCCC | 50.54 | - | |
104 | Phosphorylation | LLNLRKISSDLDGHP HHCHHHCCCCCCCCC | 22.34 | 28355574 | |
104 (in isoform 2) | Phosphorylation | - | 22.34 | 27251275 | |
105 | Phosphorylation | LNLRKISSDLDGHPV HCHHHCCCCCCCCCC | 45.74 | 23927012 | |
114 | Ubiquitination | LDGHPVPKQAFTDVA CCCCCCCCHHHCCCC | 55.26 | - | |
122 | Phosphorylation | QAFTDVATGSLGQGL HHHCCCCCCCCCCHH | 27.44 | 21712546 | |
124 | Phosphorylation | FTDVATGSLGQGLGA HCCCCCCCCCCHHHH | 25.60 | 21712546 | |
133 | Glutathionylation | GQGLGAACGMAYTGK CCHHHHHCCHHHCCC | 3.67 | 22555962 | |
135 | Sulfoxidation | GLGAACGMAYTGKYF HHHHHCCHHHCCCCC | 2.31 | 30846556 | |
140 | Acetylation | CGMAYTGKYFDKASY CCHHHCCCCCCCCCE | 34.64 | 26051181 | |
140 | Ubiquitination | CGMAYTGKYFDKASY CCHHHCCCCCCCCCE | 34.64 | - | |
144 | 2-Hydroxyisobutyrylation | YTGKYFDKASYRVYC HCCCCCCCCCEEEEE | 29.36 | - | |
144 | Acetylation | YTGKYFDKASYRVYC HCCCCCCCCCEEEEE | 29.36 | 19608861 | |
144 | Succinylation | YTGKYFDKASYRVYC HCCCCCCCCCEEEEE | 29.36 | 23954790 | |
144 | Ubiquitination | YTGKYFDKASYRVYC HCCCCCCCCCEEEEE | 29.36 | 19608861 | |
174 | Ubiquitination | MAFASIYKLDNLVAI HHHHHHHCHHCEEEE | 47.93 | - | |
190 | Phosphorylation | DINRLGQSDPAPLQH EHHHCCCCCCCCCHH | 43.70 | 23911959 | |
199 | Sulfoxidation | PAPLQHQMDIYQKRC CCCCHHHHHHHHHHH | 2.95 | 30846556 | |
202 | Phosphorylation | LQHQMDIYQKRCEAF CHHHHHHHHHHHHHH | 12.06 | 28152594 | |
204 | Ubiquitination | HQMDIYQKRCEAFGW HHHHHHHHHHHHHCC | 41.88 | 21890473 | |
204 | 2-Hydroxyisobutyrylation | HQMDIYQKRCEAFGW HHHHHHHHHHHHHCC | 41.88 | - | |
204 | Acetylation | HQMDIYQKRCEAFGW HHHHHHHHHHHHHCC | 41.88 | 19608861 | |
204 | Methylation | HQMDIYQKRCEAFGW HHHHHHHHHHHHHCC | 41.88 | 19608861 | |
204 | Ubiquitination | HQMDIYQKRCEAFGW HHHHHHHHHHHHHCC | 41.88 | 21890473 | |
212 | Ubiquitination | RCEAFGWHAIIVDGH HHHHHCCEEEEECCC | 13.87 | 21890473 | |
212 | Acetylation | RCEAFGWHAIIVDGH HHHHHCCEEEEECCC | 13.87 | 19608861 | |
212 | Ubiquitination | RCEAFGWHAIIVDGH HHHHHCCEEEEECCC | 13.87 | 19608861 | |
232 | Ubiquitination | CKAFGQAKHQPTAII HHHHCCCCCCCCEEE | 34.58 | 21890473 | |
232 | 2-Hydroxyisobutyrylation | CKAFGQAKHQPTAII HHHHCCCCCCCCEEE | 34.58 | - | |
232 | Acetylation | CKAFGQAKHQPTAII HHHHCCCCCCCCEEE | 34.58 | 16916647 | |
232 | Malonylation | CKAFGQAKHQPTAII HHHHCCCCCCCCEEE | 34.58 | 26320211 | |
232 | Ubiquitination | CKAFGQAKHQPTAII HHHHCCCCCCCCEEE | 34.58 | - | |
240 | Ubiquitination | HQPTAIIAKTFKGRG CCCCEEEEEECCCCC | 9.95 | 21890473 | |
241 | 2-Hydroxyisobutyrylation | QPTAIIAKTFKGRGI CCCEEEEEECCCCCC | 44.05 | - | |
241 | Acetylation | QPTAIIAKTFKGRGI CCCEEEEEECCCCCC | 44.05 | 19608861 | |
241 | Ubiquitination | QPTAIIAKTFKGRGI CCCEEEEEECCCCCC | 44.05 | 21906983 | |
244 | Ubiquitination | AIIAKTFKGRGITGV EEEEEECCCCCCCCC | 53.59 | - | |
246 | Methylation | IAKTFKGRGITGVED EEEECCCCCCCCCCC | 33.65 | 115918529 | |
249 | Acetylation | TFKGRGITGVEDKES ECCCCCCCCCCCCCC | 37.69 | 19608861 | |
249 | Phosphorylation | TFKGRGITGVEDKES ECCCCCCCCCCCCCC | 37.69 | 20873877 | |
249 | Ubiquitination | TFKGRGITGVEDKES ECCCCCCCCCCCCCC | 37.69 | 19608861 | |
254 | Ubiquitination | GITGVEDKESWHGKP CCCCCCCCCCCCCCC | 39.89 | 21890473 | |
254 | 2-Hydroxyisobutyrylation | GITGVEDKESWHGKP CCCCCCCCCCCCCCC | 39.89 | - | |
254 | Acetylation | GITGVEDKESWHGKP CCCCCCCCCCCCCCC | 39.89 | 23954790 | |
254 | Malonylation | GITGVEDKESWHGKP CCCCCCCCCCCCCCC | 39.89 | 26320211 | |
254 | Ubiquitination | GITGVEDKESWHGKP CCCCCCCCCCCCCCC | 39.89 | 19608861 | |
256 | Phosphorylation | TGVEDKESWHGKPLP CCCCCCCCCCCCCCC | 30.07 | 20873877 | |
260 | Ubiquitination | DKESWHGKPLPKNMA CCCCCCCCCCCHHHH | 30.41 | 21890473 | |
260 | 2-Hydroxyisobutyrylation | DKESWHGKPLPKNMA CCCCCCCCCCCHHHH | 30.41 | - | |
260 | Acetylation | DKESWHGKPLPKNMA CCCCCCCCCCCHHHH | 30.41 | 19608861 | |
260 | Malonylation | DKESWHGKPLPKNMA CCCCCCCCCCCHHHH | 30.41 | 26320211 | |
260 | Ubiquitination | DKESWHGKPLPKNMA CCCCCCCCCCCHHHH | 30.41 | 19608861 | |
262 | Ubiquitination | ESWHGKPLPKNMAEQ CCCCCCCCCHHHHHH | 12.28 | 21890473 | |
262 | Acetylation | ESWHGKPLPKNMAEQ CCCCCCCCCHHHHHH | 12.28 | 19608861 | |
262 | Ubiquitination | ESWHGKPLPKNMAEQ CCCCCCCCCHHHHHH | 12.28 | 19608861 | |
264 | Ubiquitination | WHGKPLPKNMAEQII CCCCCCCHHHHHHHH | 68.02 | - | |
264 (in isoform 2) | Phosphorylation | - | 68.02 | 27251275 | |
266 | Sulfoxidation | GKPLPKNMAEQIIQE CCCCCHHHHHHHHHH | 5.61 | 28183972 | |
268 | Ubiquitination | PLPKNMAEQIIQEIY CCCHHHHHHHHHHHH | 31.38 | 21890473 | |
268 | Acetylation | PLPKNMAEQIIQEIY CCCHHHHHHHHHHHH | 31.38 | 19608861 | |
268 | Ubiquitination | PLPKNMAEQIIQEIY CCCHHHHHHHHHHHH | 31.38 | 19608861 | |
275 | Phosphorylation | EQIIQEIYSQIQSKK HHHHHHHHHHHHHCC | 8.18 | 27273156 | |
276 | Phosphorylation | QIIQEIYSQIQSKKK HHHHHHHHHHHHCCC | 26.86 | 25159151 | |
280 | Phosphorylation | EIYSQIQSKKKILAT HHHHHHHHCCCCCCC | 48.33 | 23663014 | |
281 | 2-Hydroxyisobutyrylation | IYSQIQSKKKILATP HHHHHHHCCCCCCCC | 41.53 | - | |
281 | Acetylation | IYSQIQSKKKILATP HHHHHHHCCCCCCCC | 41.53 | 23954790 | |
281 | Ubiquitination | IYSQIQSKKKILATP HHHHHHHCCCCCCCC | 41.53 | 21906983 | |
282 | Ubiquitination | YSQIQSKKKILATPP HHHHHHCCCCCCCCC | 50.74 | - | |
283 | Ubiquitination | SQIQSKKKILATPPQ HHHHHCCCCCCCCCC | 46.84 | 21890473 | |
283 | 2-Hydroxyisobutyrylation | SQIQSKKKILATPPQ HHHHHCCCCCCCCCC | 46.84 | - | |
283 | Ubiquitination | SQIQSKKKILATPPQ HHHHHCCCCCCCCCC | 46.84 | 21906983 | |
283 (in isoform 2) | Phosphorylation | - | 46.84 | 27642862 | |
287 | Phosphorylation | SKKKILATPPQEDAP HCCCCCCCCCCCCCC | 31.86 | 29255136 | |
288 (in isoform 2) | Phosphorylation | - | 23.99 | 27251275 | |
291 | Ubiquitination | ILATPPQEDAPSVDI CCCCCCCCCCCCCCC | 63.01 | 21890473 | |
295 | Phosphorylation | PPQEDAPSVDIANIR CCCCCCCCCCCCCCC | 33.86 | 29255136 | |
295 (in isoform 2) | Phosphorylation | - | 33.86 | 27251275 | |
303 | Sulfoxidation | VDIANIRMPSLPSYK CCCCCCCCCCCCCCC | 2.04 | 28183972 | |
303 (in isoform 2) | Phosphorylation | - | 2.04 | 27251275 | |
305 | Phosphorylation | IANIRMPSLPSYKVG CCCCCCCCCCCCCCC | 43.50 | 21406692 | |
308 | Phosphorylation | IRMPSLPSYKVGDKI CCCCCCCCCCCCCCH | 42.76 | 25307156 | |
309 | Phosphorylation | RMPSLPSYKVGDKIA CCCCCCCCCCCCCHH | 14.04 | 21406692 | |
310 | Ubiquitination | MPSLPSYKVGDKIAT CCCCCCCCCCCCHHH | 44.04 | 21890473 | |
310 | Acetylation | MPSLPSYKVGDKIAT CCCCCCCCCCCCHHH | 44.04 | 25953088 | |
310 | Ubiquitination | MPSLPSYKVGDKIAT CCCCCCCCCCCCHHH | 44.04 | 21890473 | |
313 (in isoform 2) | Phosphorylation | - | 42.02 | 27251275 | |
314 | 2-Hydroxyisobutyrylation | PSYKVGDKIATRKAY CCCCCCCCHHHHHHH | 28.45 | - | |
314 | Acetylation | PSYKVGDKIATRKAY CCCCCCCCHHHHHHH | 28.45 | 23749302 | |
314 | Ubiquitination | PSYKVGDKIATRKAY CCCCCCCCHHHHHHH | 28.45 | 19608861 | |
318 | Ubiquitination | VGDKIATRKAYGQAL CCCCHHHHHHHHHHH | 16.76 | 21890473 | |
319 | Ubiquitination | GDKIATRKAYGQALA CCCHHHHHHHHHHHH | 41.42 | 21890473 | |
319 | 2-Hydroxyisobutyrylation | GDKIATRKAYGQALA CCCHHHHHHHHHHHH | 41.42 | - | |
319 | Ubiquitination | GDKIATRKAYGQALA CCCHHHHHHHHHHHH | 41.42 | 21906983 | |
321 | Phosphorylation | KIATRKAYGQALAKL CHHHHHHHHHHHHHH | 16.89 | 28152594 | |
322 | Acetylation | IATRKAYGQALAKLG HHHHHHHHHHHHHHC | 15.90 | 19608861 | |
327 | Ubiquitination | AYGQALAKLGHASDR HHHHHHHHHCCCCCC | 56.71 | 21890473 | |
327 | 2-Hydroxyisobutyrylation | AYGQALAKLGHASDR HHHHHHHHHCCCCCC | 56.71 | - | |
327 | Acetylation | AYGQALAKLGHASDR HHHHHHHHHCCCCCC | 56.71 | 23954790 | |
327 | Ubiquitination | AYGQALAKLGHASDR HHHHHHHHHCCCCCC | 56.71 | 21906983 | |
334 | Methylation | KLGHASDRIIALDGD HHCCCCCCEEEEECC | 21.51 | 115918533 | |
342 | Phosphorylation | IIALDGDTKNSTFSE EEEEECCCCCCCHHH | 37.34 | 21815630 | |
343 | 2-Hydroxyisobutyrylation | IALDGDTKNSTFSEI EEEECCCCCCCHHHH | 54.35 | - | |
343 | Acetylation | IALDGDTKNSTFSEI EEEECCCCCCCHHHH | 54.35 | 23954790 | |
343 | Sumoylation | IALDGDTKNSTFSEI EEEECCCCCCCHHHH | 54.35 | - | |
343 | Ubiquitination | IALDGDTKNSTFSEI EEEECCCCCCCHHHH | 54.35 | 21906983 | |
345 | Phosphorylation | LDGDTKNSTFSEIFK EECCCCCCCHHHHHH | 32.17 | 25159151 | |
346 | Phosphorylation | DGDTKNSTFSEIFKK ECCCCCCCHHHHHHH | 40.34 | 21712546 | |
348 | Phosphorylation | DTKNSTFSEIFKKEH CCCCCCHHHHHHHHC | 29.85 | 25159151 | |
350 (in isoform 2) | Phosphorylation | - | 6.25 | 27251275 | |
352 | 2-Hydroxyisobutyrylation | STFSEIFKKEHPDRF CCHHHHHHHHCCCCE | 64.01 | - | |
352 | Acetylation | STFSEIFKKEHPDRF CCHHHHHHHHCCCCE | 64.01 | 23954790 | |
352 | Succinylation | STFSEIFKKEHPDRF CCHHHHHHHHCCCCE | 64.01 | 23954790 | |
352 | Sumoylation | STFSEIFKKEHPDRF CCHHHHHHHHCCCCE | 64.01 | 28112733 | |
352 | Ubiquitination | STFSEIFKKEHPDRF CCHHHHHHHHCCCCE | 64.01 | - | |
353 | Acetylation | TFSEIFKKEHPDRFI CHHHHHHHHCCCCEE | 50.97 | 25953088 | |
353 | Ubiquitination | TFSEIFKKEHPDRFI CHHHHHHHHCCCCEE | 50.97 | - | |
382 | Phosphorylation | GCATRNRTVPFCSTF CCCCCCCCCCCHHHH | 35.76 | - | |
386 | S-nitrosylation | RNRTVPFCSTFAAFF CCCCCCCHHHHHHHH | 2.83 | 25040305 | |
386 | S-palmitoylation | RNRTVPFCSTFAAFF CCCCCCCHHHHHHHH | 2.83 | 29575903 | |
387 | Phosphorylation | NRTVPFCSTFAAFFT CCCCCCHHHHHHHHH | 27.26 | - | |
406 | Phosphorylation | QIRMAAISESNINLC HHHHHHHCCCCCCCC | 30.19 | 28176443 | |
408 | Phosphorylation | RMAAISESNINLCGS HHHHHCCCCCCCCCC | 35.90 | 28176443 | |
415 | Phosphorylation | SNINLCGSHCGVSIG CCCCCCCCCCCCCCC | 18.01 | 28176443 | |
420 | Phosphorylation | CGSHCGVSIGEDGPS CCCCCCCCCCCCCCC | 15.34 | 28176443 | |
427 | Phosphorylation | SIGEDGPSQMALEDL CCCCCCCCHHHHHHH | 37.81 | 28176443 | |
439 | Phosphorylation | EDLAMFRSVPTSTVF HHHHHHHCCCCCEEE | 22.60 | 21712546 | |
442 | Phosphorylation | AMFRSVPTSTVFYPS HHHHCCCCCEEECCC | 34.57 | 21712546 | |
444 | Phosphorylation | FRSVPTSTVFYPSDG HHCCCCCEEECCCCC | 19.67 | 28152594 | |
447 | Phosphorylation | VPTSTVFYPSDGVAT CCCCEEECCCCCCCC | 9.48 | 28152594 | |
449 | Phosphorylation | TSTVFYPSDGVATEK CCEEECCCCCCCCHH | 35.30 | 28152594 | |
454 | Phosphorylation | YPSDGVATEKAVELA CCCCCCCCHHHHHHH | 35.30 | 28152594 | |
456 | 2-Hydroxyisobutyrylation | SDGVATEKAVELAAN CCCCCCHHHHHHHHC | 54.07 | - | |
456 | Acetylation | SDGVATEKAVELAAN CCCCCCHHHHHHHHC | 54.07 | 26051181 | |
456 | Ubiquitination | SDGVATEKAVELAAN CCCCCCHHHHHHHHC | 54.07 | 21906983 | |
465 | Ubiquitination | VELAANTKGICFIRT HHHHHCCCCEEEEEC | 46.19 | 21890473 | |
465 | 2-Hydroxyisobutyrylation | VELAANTKGICFIRT HHHHHCCCCEEEEEC | 46.19 | - | |
465 | Acetylation | VELAANTKGICFIRT HHHHHCCCCEEEEEC | 46.19 | 26051181 | |
465 | Ubiquitination | VELAANTKGICFIRT HHHHHCCCCEEEEEC | 46.19 | 21890473 | |
468 | S-palmitoylation | AANTKGICFIRTSRP HHCCCCEEEEECCCC | 2.94 | 29575903 | |
472 | Phosphorylation | KGICFIRTSRPENAI CCEEEEECCCCCCEE | 25.03 | 21712546 | |
473 | Ubiquitination | GICFIRTSRPENAII CEEEEECCCCCCEEE | 35.67 | 21890473 | |
481 | Phosphorylation | RPENAIIYNNNEDFQ CCCCEEEECCCCCCC | 13.01 | 28152594 | |
489 (in isoform 2) | Phosphorylation | - | 6.57 | 27642862 | |
493 | 2-Hydroxyisobutyrylation | DFQVGQAKVVLKSKD CCCCCEEEEEEECCC | 25.62 | - | |
493 | Acetylation | DFQVGQAKVVLKSKD CCCCCEEEEEEECCC | 25.62 | 27452117 | |
493 | Ubiquitination | DFQVGQAKVVLKSKD CCCCCEEEEEEECCC | 25.62 | - | |
497 | Acetylation | GQAKVVLKSKDDQVT CEEEEEEECCCCCEE | 43.80 | 25953088 | |
497 | Ubiquitination | GQAKVVLKSKDDQVT CEEEEEEECCCCCEE | 43.80 | - | |
499 | 2-Hydroxyisobutyrylation | AKVVLKSKDDQVTVI EEEEEECCCCCEEEE | 64.83 | - | |
499 | Acetylation | AKVVLKSKDDQVTVI EEEEEECCCCCEEEE | 64.83 | 23749302 | |
499 | Ubiquitination | AKVVLKSKDDQVTVI EEEEEECCCCCEEEE | 64.83 | - | |
523 | 2-Hydroxyisobutyrylation | LAAAELLKKEKINIR HHHHHHHHHCCCCEE | 72.08 | - | |
523 | Acetylation | LAAAELLKKEKINIR HHHHHHHHHCCCCEE | 72.08 | 25953088 | |
523 | Ubiquitination | LAAAELLKKEKINIR HHHHHHHHHCCCCEE | 72.08 | - | |
526 | 2-Hydroxyisobutyrylation | AELLKKEKINIRVLD HHHHHHCCCCEEEEC | 50.35 | - | |
538 | Ubiquitination | VLDPFTIKPLDRKLI EECCCCCCCCCCEEH | 36.15 | 21890473 | |
538 | 2-Hydroxyisobutyrylation | VLDPFTIKPLDRKLI EECCCCCCCCCCEEH | 36.15 | - | |
538 | Acetylation | VLDPFTIKPLDRKLI EECCCCCCCCCCEEH | 36.15 | 25953088 | |
538 | Succinylation | VLDPFTIKPLDRKLI EECCCCCCCCCCEEH | 36.15 | 23954790 | |
538 | Ubiquitination | VLDPFTIKPLDRKLI EECCCCCCCCCCEEH | 36.15 | - | |
543 | Malonylation | TIKPLDRKLILDSAR CCCCCCCEEHHHHCC | 39.28 | 26320211 | |
543 | Ubiquitination | TIKPLDRKLILDSAR CCCCCCCEEHHHHCC | 39.28 | - | |
546 | Ubiquitination | PLDRKLILDSARATK CCCCEEHHHHCCCCC | 6.53 | 21890473 | |
548 | Phosphorylation | DRKLILDSARATKGR CCEEHHHHCCCCCCC | 19.06 | - | |
563 | Phosphorylation | ILTVEDHYYEGGIGE EEEEECCEECCCHHH | 18.61 | - | |
564 | Phosphorylation | LTVEDHYYEGGIGEA EEEECCEECCCHHHH | 12.51 | - | |
574 | Phosphorylation | GIGEAVSSAVVGEPG CHHHHHHHHCCCCCC | 20.63 | - | |
595 | Phosphorylation | AVNRVPRSGKPAELL EECCCCCCCCHHHHH | 45.13 | 23911959 | |
597 | 2-Hydroxyisobutyrylation | NRVPRSGKPAELLKM CCCCCCCCHHHHHHH | 42.15 | - | |
597 | Acetylation | NRVPRSGKPAELLKM CCCCCCCCHHHHHHH | 42.15 | 19608861 | |
597 | Malonylation | NRVPRSGKPAELLKM CCCCCCCCHHHHHHH | 42.15 | 26320211 | |
597 | Ubiquitination | NRVPRSGKPAELLKM CCCCCCCCHHHHHHH | 42.15 | 19608861 | |
603 | 2-Hydroxyisobutyrylation | GKPAELLKMFGIDRD CCHHHHHHHHCCCHH | 44.82 | - | |
603 | Acetylation | GKPAELLKMFGIDRD CCHHHHHHHHCCCHH | 44.82 | 19608861 | |
603 | Succinylation | GKPAELLKMFGIDRD CCHHHHHHHHCCCHH | 44.82 | 23954790 | |
604 | Sulfoxidation | KPAELLKMFGIDRDA CHHHHHHHHCCCHHH | 3.62 | 21406390 | |
605 | Acetylation | PAELLKMFGIDRDAI HHHHHHHHCCCHHHH | 8.09 | 19608861 | |
605 | Ubiquitination | PAELLKMFGIDRDAI HHHHHHHHCCCHHHH | 8.09 | 19608861 | |
609 | Methylation | LKMFGIDRDAIAQAV HHHHCCCHHHHHHHH | 33.08 | 66701869 | |
611 | Acetylation | MFGIDRDAIAQAVRG HHCCCHHHHHHHHHH | 10.42 | 19608861 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TKT_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TKT_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1; LYS-6; LYS-11; LYS-144;LYS-204; LYS-241; LYS-260; LYS-314; LYS-597 AND LYS-603, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-232, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-295, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-275 AND THR-287, ANDMASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-287, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-275, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-275, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-275, AND MASSSPECTROMETRY. |